$ZCMD
Zhongchao Inc Stock $zcmd

$zcmd Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024037934 Filed on April 30, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$9.058M	$19.43M	$6.856M
YoY Change	32.12%	37.33%	-10.74%
Cost Of Revenue	$4.869M	$10.92M	$5.558M
YoY Change	-12.4%	40.11%	49.8%
Gross Profit	$4.189M	$8.512M	$1.298M
YoY Change	222.74%	33.91%	-67.31%
Gross Profit Margin	46.25%	43.8%	18.93%
Selling, General & Admin	$4.824M	$13.41M	$4.537M
YoY Change	6.33%	50.66%	-5.64%
% of Gross Profit	115.16%	157.52%	349.54%
Research & Development	$215.0K	$514.4K	$258.2K
YoY Change	-16.74%	25.0%	-24.67%
% of Gross Profit	5.13%	6.04%	19.9%
Depreciation & Amortization	$242.1K	$518.5K	$254.9K
YoY Change	-5.03%	114.39%	28.38%
% of Gross Profit	5.78%	6.09%	19.64%
Operating Expenses	$5.039M	$21.80M	$4.795M
YoY Change	5.09%	134.09%	-6.91%
Operating Profit	-$850.0K	-$13.28M	-$3.497M
YoY Change	-75.69%	349.62%	196.35%
Interest Expense	$180.0K	$892.0K	$59.10K
YoY Change	204.57%	528.12%	-46.37%
% of Operating Profit
Other Income/Expense, Net	$285.0K	$1.070M	$509.8K
YoY Change	-44.09%	307.61%	-699.45%
Pretax Income	-$6.795M	-$11.98M	-$2.928M
YoY Change	132.05%	369.69%	153.55%
Income Tax	-$267.0K	-$669.8K	-$12.38K
% Of Pretax Income
Net Earnings	-$6.614M	-$11.34M	-$3.034M
YoY Change	117.96%	301.65%	297.76%
Net Earnings / Revenue	-73.02%	-58.33%	-44.26%
Basic Earnings Per Share		-$4.35
Diluted Earnings Per Share	-$2.54	-$4.35	-$0.12
COMMON SHARES
Basic Shares Outstanding		2.603M shares
Diluted Shares Outstanding		2.603M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.45M	$13.45M	$12.04M
YoY Change	11.7%	11.7%	-15.29%
Cash & Equivalents	$7.549M	$7.549M	$11.52M
Short-Term Investments	$5.898M	$5.898M	$518.4K
Other Short-Term Assets	$451.4K	$1.656M	$493.0K
YoY Change	-8.44%	23.35%	-36.03%
Inventory	$592.4K	$592.0K	$189.1K
Prepaid Expenses	$1.386M		$1.028M
Receivables	$2.553M	$2.553M	$6.773M
Other Receivables		$463.0K	$2.066M
Total Short-Term Assets	$18.71M	$18.71M	$22.70M
YoY Change	-17.59%	-17.59%	-16.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.222M	$4.019M	$3.891M
YoY Change	-17.19%	-27.69%	-5.76%
Goodwill			$5.768M
YoY Change
Intangibles	$17.54K		$912.1K
YoY Change	-98.08%		2914.16%
Long-Term Investments	$1.145M	$1.311M	$1.264M
YoY Change	-9.38%	3.73%	-41.03%
Other Assets	$358.0K	$358.0K	$2.104M
YoY Change	-82.99%	-82.99%	-10.76%
Total Long-Term Assets	$5.706M	$5.706M	$15.91M
YoY Change	-64.14%	-64.14%	76.51%
TOTAL ASSETS
Total Short-Term Assets	$18.71M	$18.71M	$22.70M
Total Long-Term Assets	$5.706M	$5.706M	$15.91M
Total Assets	$24.42M	$24.42M	$38.61M
YoY Change	-36.77%	-36.77%	6.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$683.9K	$684.0K	$140.8K
YoY Change	385.63%	385.69%	261.76%
Accrued Expenses	$1.149M	$1.003M	$1.336M
YoY Change	-14.01%	-13.33%	25.61%
Deferred Revenue	$838.8K		$395.3K
YoY Change	112.22%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.678M	$2.678M	$4.165M
YoY Change	-35.69%	-35.7%	16.07%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$572.0K	$572.0K	$1.222M
YoY Change	-53.19%	-53.19%	985.22%
Total Long-Term Liabilities	$572.0K	$572.0K	$1.222M
YoY Change	-53.19%	-53.19%	985.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.678M	$2.678M	$4.165M
Total Long-Term Liabilities	$572.0K	$572.0K	$1.222M
Total Liabilities	$3.378M	$6.410M	$5.595M
YoY Change	-39.62%	-26.2%	51.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.268M		$4.124M
YoY Change	-276.24%		-42.57%
Common Stock			$2.054K
YoY Change			5.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.01M	$18.01M	$29.93M
YoY Change
Total Liabilities & Shareholders Equity	$24.42M	$24.42M	$38.61M
YoY Change	-36.77%	-36.77%	6.47%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	-$6.614M	-$11.34M	-$3.034M
YoY Change	117.96%	301.65%	297.76%
Depreciation, Depletion And Amortization	$242.1K	$518.5K	$254.9K
YoY Change	-5.03%	114.39%	28.38%
Cash From Operating Activities	$1.907M	$54.23K	$134.9K
YoY Change	1314.15%	-108.19%	-89.19%
INVESTING ACTIVITIES
Capital Expenditures	$827.4K	$839.7K	$1.575M
YoY Change	-47.47%	-48.04%	2010.37%
Acquisitions		$233.3K
YoY Change		44.94%
Other Investing Activities	-$4.866M	-$2.915M	$1.390M
YoY Change	-450.19%	68.42%	12164.08%
Cash From Investing Activities	-$5.693M	-$3.755M	-$185.7K
YoY Change	2966.41%	12.19%	-316.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			270.0
YoY Change
NET CHANGE
Cash From Operating Activities	1.907M	$54.23K	134.9K
Cash From Investing Activities	-5.693M	-$3.755M	-185.7K
Cash From Financing Activities			270.0
Net Change In Cash	-3.786M	-$3.972M	-50.52K
YoY Change	7394.06%	65.87%	-103.79%
FREE CASH FLOW
Cash From Operating Activities	$1.907M	$54.23K	$134.9K
Capital Expenditures	$827.4K	$839.7K	$1.575M
Free Cash Flow	$1.080M	-$785.5K	-$1.440M
YoY Change	-174.98%	-65.51%	-222.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	zcmd	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39229
CY2023	dei	Entity Registrant Name EntityRegistrantName	ZHONGCHAO INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Nanxi Creative Center
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 216
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	841 Yan’an Middle Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Jing’An District
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	200040
CY2023	dei	Security12b Title Security12bTitle	Class A Ordinary shares, par value $0.001
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	5395
CY2023	dei	Auditor Name AuditorName	Marcum Asia CPAs LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7548694	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11520453	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	5897809	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	518416	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2552738	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6772988	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	592382	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	189106	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1386307	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1027989	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	115989	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	281694	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1840000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	226179	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	451422	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	493040	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	18711046	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	22704160	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1145404	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1179300	usd
CY2023Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	165871	usd
CY2022Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	84606	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5767504	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3222252	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3890947	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	239481	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	304787	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17539	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	912054	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	796653	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1666777	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	357878	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1864729	usd
CY2023Q4	us-gaap	Assets Assets	24416643	usd
CY2022Q4	us-gaap	Assets Assets	38614345	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	683937	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	140834	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	838838	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	395263	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6734	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2292765	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	236294	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	480633	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	912558	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	855540	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2678361	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4165035	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	571862	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1221845	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	128250	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	208200	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3378473	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5595080	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25133933	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24998388	usd
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1371168	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1315017	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7268025	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4124037	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1232901	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-511824	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18006781	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29928222	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	3031389	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	3091043	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21038170	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33019265	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24416643	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38614345	usd
CY2023	us-gaap	Revenues Revenues	19433945	usd
CY2022	us-gaap	Revenues Revenues	14151516	usd
CY2021	us-gaap	Revenues Revenues	16296770	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	10921753	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	7794852	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	6857944	usd
CY2023	us-gaap	Gross Profit GrossProfit	8512192	usd
CY2022	us-gaap	Gross Profit GrossProfit	6356664	usd
CY2021	us-gaap	Gross Profit GrossProfit	9438826	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6710757	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2099968	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3137316	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6697309	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6799634	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5863373	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	514411	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	411524	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	758878	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1719442	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5617865	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	536206	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	21795990	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	9311126	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9759567	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-13283798	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2954462	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-320741	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	237054	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	142014	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	175987	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1069745	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	262442	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	34001	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11976999	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2550006	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110753	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-669760	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	272313	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-349418	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-11307239	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2822319	usd
CY2021	us-gaap	Profit Loss ProfitLoss	238665	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28672	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	118572	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11335911	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2940891	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	238665	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-809403	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1715262	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	281793	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12116642	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4537581	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	520458	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-59654	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	112139	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12056988	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4649722	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	520458	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2603354	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2599776	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2493851	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.354
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.131
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.096
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31834141	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	211823	usd
CY2021	us-gaap	Profit Loss ProfitLoss	238665	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	281793	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32566422	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1850744	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	160777	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2978903	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2822319	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1715262	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33019265	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	135547	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-11307239	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-809403	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21038170	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-11307239	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2822319	usd
CY2021	us-gaap	Profit Loss ProfitLoss	238665	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1247907	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	753447	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1449827	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	518493	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	383286	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	341608	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1688078	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	96921	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5617865	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	536206	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	405121	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	347025	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	361369	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	135547	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	160777	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	211823	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-739227	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	134125	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1346616	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	654980	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-240489	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-58403	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	81265	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-65394	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-229	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-80	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-13758	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2789772	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1076292	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	104230	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	388706	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	659496	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-171144	usd
CY2023	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties	-112980	usd
CY2022	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties	118888	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	409771	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	193833	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-27685	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-66148	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1302009	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	548591	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	103825	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-375144	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	456078	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	369249	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	496	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-102326	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3557	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	905733	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	81554	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-167585	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-4430	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-428363	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-306392	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-362567	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	54229	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-661740	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2861848	usd
CY2023	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	839736	usd
CY2022	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1615905	usd
CY2021	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1799860	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	31634	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1112440	usd
CY2022	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	245467	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	6317257	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	996638	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	1592844	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	533891	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	1678367	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	708129	usd
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	150000	usd
CY2022	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	3055432	usd
CY2023	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	220310	usd
CY2022	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	139694	usd
CY2021	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	-387549	usd
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	833226	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	1032219	usd
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	3725211	usd
CY2023	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	2390776	usd
CY2022	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	1806772	usd
CY2021	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	1075098	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	6206	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3754655	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3346658	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4017284	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1850744	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1850744	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-271333	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-236875	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2529	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3971759	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2394529	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1157965	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11520453	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13914982	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15072947	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7548694	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11520453	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13914982	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	114501	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	134232	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	91464	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	71726	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1774723	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	555639	usd
CY2023	zcmd	Decrease In Right Of Use Assets And Operating Lease Obligations DecreaseInRightOfUseAssetsAndOperatingLeaseObligations	-579491	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	210868	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	233267	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	160940	usd
CY2019Q3	us-gaap	Shares Issued SharesIssued	135007	shares
CY2019Q3	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	675000	shares
CY2023	zcmd	Percentage Of Economic Beneficial Interest PercentageOfEconomicBeneficialInterest	0.0518	pure
CY2023	zcmd	Ownership Voting Percentage OwnershipVotingPercentage	0.0131	pure
CY2019Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	20000000	cny
CY2019Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	2900000	usd
CY2019Q3	zcmd	Initial Equity Interest Pledge Agreement InitialEquityInterestPledgeAgreement	P20Y
CY2019Q3	zcmd	Service Fees ServiceFees	1	pure
CY2023	zcmd	Foreign Currency Exchange Rate Translations Balance Sheet Excep Equity ForeignCurrencyExchangeRateTranslationsBalanceSheetExcepEquity	7.0999	pure
CY2022	zcmd	Foreign Currency Exchange Rate Translations Balance Sheet Excep Equity ForeignCurrencyExchangeRateTranslationsBalanceSheetExcepEquity	6.8972	pure
CY2023	zcmd	Foreign Currency Exchange Rate Translations Statements Of Iincome And Comprehensive Income And Statements Of Cashflows ForeignCurrencyExchangeRateTranslationsStatementsOfIincomeAndComprehensiveIncomeAndStatementsOfCashflows	7.0809	pure
CY2022	zcmd	Foreign Currency Exchange Rate Translations Statements Of Iincome And Comprehensive Income And Statements Of Cashflows ForeignCurrencyExchangeRateTranslationsStatementsOfIincomeAndComprehensiveIncomeAndStatementsOfCashflows	6.729	pure
CY2021	zcmd	Foreign Currency Exchange Rate Translations Statements Of Iincome And Comprehensive Income And Statements Of Cashflows ForeignCurrencyExchangeRateTranslationsStatementsOfIincomeAndComprehensiveIncomeAndStatementsOfCashflows	6.4508	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Use of estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities on the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, management reviews these estimates and assumptions using the currently available information. Changes in facts and circumstances may cause the Company to revise its estimates. The Company bases its estimates on past experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Estimates are used when accounting for items and matters including, but not limited to, fair value of the Company’s ordinary shares, fair value of the Company’s subsidiaries, determinations of the useful lives and valuation of long-lived assets, valuation of goodwill, estimates of allowances for doubtful accounts, valuation of deferred tax assets, and other provisions and contingencies.</p>
CY2022	us-gaap	Revenues Revenues	14151516	usd
CY2021	us-gaap	Revenues Revenues	16296770	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1247907	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	753447	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1449827	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1247907	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	543315	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1449827	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2197	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	207269	usd
CY2023	zcmd	Prepayment Prepayment	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepayments</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepayments represent amounts advanced to suppliers for providing services or products to the Company. The suppliers usually require advance payments when the Company orders services or products and the prepayments will be utilized to offset the Company’s future payments. These amounts are unsecured, non-interest bearing and generally short-term in nature.</p>
CY2023	zcmd	Government Grants GovernmentGrants	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in an equity security</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity securities not accounted for using the equity method are carried at fair value with unrealized gains and losses recorded in the consolidated statements of operations and comprehensive (loss) income, according to ASC 321 “Investments — Equity Securities”, which the Company adopted beginning January 1, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2023 and 2022, the Company had investment in one equity security. The Company elected to record an equity investment in privately held companies using the measurement alternative at cost, less impairment, with subsequent adjustments for observable price changes resulting from orderly transactions for identical or similar investments of the same issuer. As a practical expedient, the Company uses Net Asset Value (“NAV”) or its equivalent to measure the fair value of the investment in the fund. NAV is primarily determined based on information provided by financial institution.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The equity investment in privately held companies accounted for using the measurement alternative are subject to periodic impairment reviews. The Company’s impairment analysis considers both qualitative and quantitative factors that may have a significant effect on the fair value of the equity security, including consideration of the impact of the COVID-19 pandemic.</p>
CY2023Q4	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.05	pure
CY2023	zcmd	Disposal The Prepayments For Lease Of Land DisposalThePrepaymentsForLeaseOfLand	285553	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	536206	usd
CY2023	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	5617865	usd
CY2023	zcmd	Other Revenues Percentage OtherRevenuesPercentage	0.001	pure
CY2022	zcmd	Other Revenues Percentage OtherRevenuesPercentage	0.003	pure
CY2021	zcmd	Other Revenues Percentage OtherRevenuesPercentage	0.012	pure
CY2023	us-gaap	Revenues Revenues	19433945	usd
CY2023	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	707493	usd
CY2022	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	817345	usd
CY2021	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	804730	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	514411	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	411524	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	758878	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	4197993	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	989900	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2204233	usd
CY2023	zcmd	Value Added Tax ValueAddedTax	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Value added tax</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to value added tax (“VAT”) and related surcharges on the revenues earned for both sales of products and rendering of services in the PRC. The applicable rate of value added tax is 6% on services and 13% on sales of products. The related surcharges for revenues derived from provision medical courses are deducted from gross receipts to arrive at net revenues.</p>
CY2023Q4	zcmd	Value Added Taxs ValueAddedTaxs	0.06	pure
CY2023	zcmd	Sale Of Products SaleOfProducts	0.13	pure
CY2023	zcmd	Amount Of Tax Benefit AmountOfTaxBenefit	0.50	pure
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reclassification</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain items in the financial statements of comparative period have been reclassified to conform to the financial statements for the current period. The reclassification has no impact on the total assets and total liabilities as of December 31, 2022 or on the statements of operations for the year ended December 31, 2022.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant risks and uncertainties</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Assets that potentially subject the Company to significant concentration of credit risk primarily consist of cash and cash equivalents. The maximum exposure of such assets to credit risk is their carrying amount as at the balance sheet dates. As of December 31, 2023, the Company held cash and cash equivalents of $7,548,694 and certificate of deposits of $5,241,677 included in short-term investment, among which were $5,951,558 cash was deposited in financial institutions located in Mainland China, and each bank account is insured by the government authority with the maximum limit of RMB 500,000 (equivalent to approximately $70,424). The Company also had cash equivalent of $4,740,686 that was invested in highly liquid investments with original maturities of three months or less in financial instructions located in Mainland China that was not insured by the aforementioned deposit insurance. The Company held cash of $254,876 deposited in the financial institutions in the United States, and each bank account is insured with the maximum limit of $250,000 by Federal Deposit Insurance Corporation (“FDIC”) insurance. In addition, the Company maintains certain bank accounts in Japan with cash balance of $1,453,590 which is fully insured by the Deposit Insurance Corporation of Japan (“DICJ”). The Company also had cash of $389,661 that was deposited at certain investment accounts with financial institution located in Hong Kong. These cash deposits are not insured by FDIC insurance or other insurance. To limit exposure to credit risk relating to deposits, the Company primarily place cash and cash equivalent deposits with large financial institutions which management believes are of high credit quality and the Company also continually monitors their credit worthiness.</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency risk</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all of the Company’s operating activities and the Company’s assets and liabilities are denominated in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the Peoples’ Bank of China (“PBOC”) or other authorized financial institutions at exchange rates quoted by PBOC. Approval of foreign currency payments by the PBOC or other regulatory institutions requires submitting a payment application form together with suppliers’ invoices and signed contracts. The value of RMB is subject to changes in central government policies and to international economic and political developments affecting supply and demand in the China Foreign Exchange Trading System market.</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other risk</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s operations are carried out in China. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and legal environments in the PRC as well as by the general state of the PRC’s economy. In addition, the Company’s business may be influenced by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, rates and methods of taxation among other factors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s business, financial condition and results of operations may also be negatively impacted by risks related to natural disasters, extreme weather conditions, health epidemics and other catastrophic incidents, such as the COVID-19 outbreak and spread. Management has concluded that it is not reasonably possible that the virus could have a negative effect on the Company’s financial position and results of its operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4740686	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	254876	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	1453590	usd
CY2023Q4	us-gaap	Investments And Cash InvestmentsAndCash	389661	usd
CY2021Q4	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	708129	usd
CY2021Q4	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	4568000	cny
CY2022Q1	zcmd	Cash Consideration CashConsideration	25000000	cny
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Rate NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationRate	0.0667	pure
CY2022Q3	zcmd	Cash Consideration CashConsideration	3100000	usd
CY2022Q3	zcmd	Cash Consideration CashConsideration	20600000	cny
CY2022Q3	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Rate NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationRate	0.0667	pure
CY2023	zcmd	Estimated Useful Life EstimatedUsefulLife	P3Y
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage	0.0667	pure
CY2023	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	393816	usd
CY2023	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	2713000	cny
CY2023	zcmd	Cash Consideration CashConsideration	148610	usd
CY2023	zcmd	Cash Consideration CashConsideration	1000000	cny
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	654980	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-240489	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-58403	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	186793	usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	205726	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	116899	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	128194	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	181337	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	88720	usd
CY2023Q4	zcmd	Others Others	153186	usd
CY2022Q4	zcmd	Others Others	70400	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	451422	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	493040	usd
CY2023	us-gaap	Proceeds From Sale Of Land Heldforinvestment ProceedsFromSaleOfLandHeldforinvestment	1323308	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	281694	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1840000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	196581	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	379879	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3222252	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3890947	usd
CY2023	us-gaap	Depreciation Depreciation	172394	usd
CY2022	us-gaap	Depreciation Depreciation	241842	usd
CY2021	us-gaap	Depreciation Depreciation	312898	usd
CY2021Q2	us-gaap	Payments To Acquire Land PaymentsToAcquireLand	1397317	usd
CY2022	us-gaap	Proceeds From Sale Of Land Heldforinvestment ProceedsFromSaleOfLandHeldforinvestment	1323308	usd
CY2023	zcmd	Carrying Value Of Disposed Buildings And Office Equipment CarryingValueOfDisposedBuildingsAndOfficeEquipment	1433889	usd
CY2022Q4	zcmd	Prepayments For Lease Of Land Gross PrepaymentsForLeaseOfLandGross	401031	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	96244	usd
CY2022Q4	zcmd	Prepayments For Lease Of Land Net PrepaymentsForLeaseOfLandNet	304787	usd
CY2023	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	10561	usd
CY2022	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	22226	usd
CY2021	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	23185	usd
CY2023Q2	zcmd	Prepayments For Lease Of Land PrepaymentsForLeaseOfLand	285553	usd
CY2023	us-gaap	Principal Investment Gains Losses PrincipalInvestmentGainsLosses	229	usd
CY2022	us-gaap	Principal Investment Gains Losses PrincipalInvestmentGainsLosses	80	usd
CY2021	us-gaap	Principal Investment Gains Losses PrincipalInvestmentGainsLosses	13758	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	33559	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	140951	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17539	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	912054	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	335538	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	119218	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5525	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	536206	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5020	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5020	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4985	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2514	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17539	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1145404	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1179300	usd
CY2020Q4	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	1217039	usd
CY2020Q4	zcmd	Partnership Interest Percentage PartnershipInterestPercentage	0.28	pure
CY2021Q4	us-gaap	Other Investments OtherInvestments	150000	usd
CY2021	us-gaap	Subsidiary Or Equity Method Investee Cumulative Percentage Ownership After All Transactions SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions	0.006	pure
CY2023	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	13408	usd
CY2022	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	2463	usd
CY2023Q4	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	165871	usd
CY2023	zcmd	Percentage Of Investment Ownership PercentageOfInvestmentOwnership	0.007	pure
CY2023	zcmd	Upward Adjustments In Investments In An Equity Security UpwardAdjustmentsInInvestmentsInAnEquitySecurity	81625	usd
CY2022	zcmd	Downward Adjustments In Investments In An Equity Security DownwardAdjustmentsInInvestmentsInAnEquitySecurity	65394	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	135746	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	379712	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	227884	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	296866	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	95184	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	83367	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	403001	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	50743	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	95595	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	912558	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	855540	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	128570	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	354794	usd
CY2023Q4	zcmd	Local Taxes Payable LocalTaxesPayable	7176	usd
CY2022Q4	zcmd	Local Taxes Payable LocalTaxesPayable	24918	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	135746	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	379712	usd
CY2023	zcmd	Applicable Tax Rate Description ApplicableTaxRateDescription	The applicable tax rate for the first HKD$2 million of assessable profits is 8.25% and assessable profits above HKD$2 million will continue to be subject to the rate of 16.5% for corporations in Hong Kong, effective from the year of assessment 2018/2019. Before that, the applicable tax rate was 16.5% for corporations in Hong Kong.
CY2023	zcmd	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercent	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.25	pure
CY2023	zcmd	Enterprise Income Tax Description EnterpriseIncomeTaxDescription	SMEs are entitled to a reduced EIT rate of a reduced EIT rate of 20%, 75.0% reduction of taxable income for the first RMB 3,000,000 and no reduction for the remaining taxable income for the year ended December 31, 2023; 87.5% reduction of taxable income for the first RMB1,000,000 taxable income and 75% reduction of taxable income between RMB 1,000,000 and RMB 3,000,000, and no reduction for the remaining taxable income for the year ended December 31, 2022; 87.5% reduction of taxable income for the first RMB1,000,000 taxable income and 50% reduction of taxable income between RMB 1,000,000 and RMB 3,000,000, and no reduction for the remaining taxable income for the year ended December 31, 2021.
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11527235	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1243361	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	631917	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-449764	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1306645	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-742670	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11976999	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2550006	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110753	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	69467	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	138188	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	997198	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-739227	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	134125	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1346616	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-669760	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	272313	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-349418	usd
CY2023Q4	zcmd	Lease Liabilities LeaseLiabilities	109499	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0076	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0211	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.3411	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0181	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.1272	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-1.6736	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0261	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0122	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.5484	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.0357	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.0306	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-1.0455	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.1963	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.3422	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	1.0753	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0331	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1391	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0559	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1068	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	3.1549	pure
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	47503	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	842295	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	25790	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1049699	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1052209	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	186497	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	178764	usd
CY2022Q4	zcmd	Changes In Fair Value Of Shortterm Investments ChangesInFairValueOfShorttermInvestments	50502	usd
CY2022Q4	zcmd	Downward Adjustments In Investment In An Equity Security DownwardAdjustmentsInInvestmentInAnEquitySecurity	13733	usd
CY2022Q4	zcmd	Lease Liabilities LeaseLiabilities	71024	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	26727	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	51817	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	346059	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	81910	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	715989	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	339495	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	357878	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1864729	usd
CY2022Q4	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Intangible Assets DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets	208200	usd
CY2023Q4	zcmd	Changes In Fair Value Of Shortterm Investment ChangesInFairValueOfShorttermInvestment	137546	usd
CY2023Q4	zcmd	Upward Adjustments In Investment In An Equity Security UpwardAdjustmentsInInvestmentInAnEquitySecurity	3333	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	114666	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	81910	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	218764	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	346059	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	81910	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	128250	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	208200	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9089697	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	7166560	usd
CY2023	zcmd	Net Operating Loss Carryforwards Description NetOperatingLossCarryforwardsDescription	The Company also has net operating loss carryforwards from PRC of 6,115,987 which expire starting in 2025 through 2028.
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	716600	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	339495	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1470344	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1470344	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.50	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit	0.105	pure
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11335911	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2940891	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	238665	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2603354	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2599776	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2493851	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.354
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.131
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.096
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	226178	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of Class A Ordinary Shares and Class B Class A Ordinary Shares have the same rights except for voting and conversion rights. In respect of matters requiring a shareholder vote, each Class A Ordinary Share will be entitled to 1 vote and each Class B Ordinary Share will be entitled to 15 votes.
CY2023	zcmd	Ordinary Share Issued OrdinaryShareIssued	135007	shares
CY2023Q4	zcmd	Economic Beneficial Interest Rate EconomicBeneficialInterestRate	0.0518	pure
CY2023Q4	zcmd	Voting Interest VotingInterest	0.0131	pure
CY2023Q4	zcmd	Aftertax Profits AftertaxProfits	0.10	pure
CY2023Q4	zcmd	Reserve Funds ReserveFunds	0.50	pure
CY2023Q4	zcmd	Accrued Statutory Reserve AccruedStatutoryReserve	56151	usd
CY2022Q4	zcmd	Accrued Statutory Reserve AccruedStatutoryReserve	115963	usd
CY2021Q4	zcmd	Accrued Statutory Reserve AccruedStatutoryReserve	397552	usd
CY2023	zcmd	Percentage Of Retained Earning PercentageOfRetainedEarning	0.10	pure
CY2022	zcmd	Percentage Of Retained Earning PercentageOfRetainedEarning	0.10	pure
CY2021	zcmd	Percentage Of Retained Earning PercentageOfRetainedEarning	0.10	pure
CY2023Q4	zcmd	Statutory Reserve Funds StatutoryReserveFunds	1371168	usd
CY2022Q4	zcmd	Statutory Reserve Funds StatutoryReserveFunds	1315017	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	13370283	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	13314132	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	42708	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	25.3
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1800	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.6
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	13788	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	23.7
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	30720	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	25.2
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1800	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1800	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	11.6
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	30720	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	25.2
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	135547	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	160777	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	211823	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Revenues Revenues	19433945	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	10921753	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	21795990	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-11307239	usd
CY2022	us-gaap	Revenues Revenues	14151516	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	7794852	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	9311126	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2822319	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	24416643	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	38614345	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	796653	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1666777	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	236294	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	480633	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	571862	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1221845	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	808156	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1702478	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M7D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M25D
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0475	pure
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0475	pure
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	412891	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	498166	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	426152	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	427278	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	409595	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	480636	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	268046	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	184128	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	172841	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	172841	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	86420	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	884276	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	76120	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	808156	usd
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent		usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2493851	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2599776	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2603354	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.096
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.131
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.354
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2021	zcmd	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2023	zcmd	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2021	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties		usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse		usd
CY2021	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse		usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2023	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi		usd
CY2022	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi		usd
CY2023	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries		usd
CY2021	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries		usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	zcmd	Decrease In Right Of Use Assets And Operating Lease Obligations DecreaseInRightOfUseAssetsAndOperatingLeaseObligations		usd
CY2021	zcmd	Decrease In Right Of Use Assets And Operating Lease Obligations DecreaseInRightOfUseAssetsAndOperatingLeaseObligations		usd
CY2023	us-gaap	Notes Issued1 NotesIssued1		usd
CY2021	us-gaap	Notes Issued1 NotesIssued1		usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	zcmd	Disposal The Prepayments For Lease Of Land DisposalThePrepaymentsForLeaseOfLand		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2021	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent		usd
CY2023Q4	zcmd	Prepayments For Lease Of Land Gross PrepaymentsForLeaseOfLandGross		usd
CY2023Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts		usd
CY2023Q4	zcmd	Prepayments For Lease Of Land Net PrepaymentsForLeaseOfLandNet		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive		usd
CY2022Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent		usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets		usd
CY2023Q4	zcmd	Changes In Fair Value Of Shortterm Investments ChangesInFairValueOfShorttermInvestments		usd
CY2023Q4	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Intangible Assets DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIntangibleAssets		usd
CY2022Q4	zcmd	Changes In Fair Value Of Shortterm Investment ChangesInFairValueOfShorttermInvestment		usd
CY2022Q4	zcmd	Upward Adjustments In Investment In An Equity Security UpwardAdjustmentsInInvestmentInAnEquitySecurity		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome		usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease		usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued		usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2493851	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2599776	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2603354	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.096
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.131
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.354
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001785566
CY2023	dei	Trading Symbol TradingSymbol	ZCMD

Files In Submission

Name	View Source	Status
0001213900-24-037934-index-headers.html	Edgar Link	pending
0001213900-24-037934-index.html	Edgar Link	pending
0001213900-24-037934.txt	Edgar Link	pending
0001213900-24-037934-xbrl.zip	Edgar Link	pending
ea0204387-20f_zhongchao.htm	Edgar Link	pending
ea020438701ex12-1_zhong.htm	Edgar Link	pending
ea020438701ex12-2_zhong.htm	Edgar Link	pending
ea020438701ex13-1_zhong.htm	Edgar Link	pending
ea020438701ex15-1_zhong.htm	Edgar Link	pending
ea020438701ex15-2_zhong.htm	Edgar Link	pending
ea020438701ex2-3_zhong.htm	Edgar Link	pending
ea020438701ex8-1_zhong.htm	Edgar Link	pending
ea020438701ex97-1_zhong.htm	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-1_002.jpg	Edgar Link	pending
ex15-1_003.jpg	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
fin_003.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zcmd-20231231.xsd	Edgar Link	pending
zcmd-20231231_def.xml	Edgar Link	unprocessable
zcmd-20231231_pre.xml	Edgar Link	unprocessable
ea0204387-20f_zhongchao_htm.xml	Edgar Link	completed
zcmd-20231231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
zcmd-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZCMD
Zhongchao Inc Stock $zcmd

2023 Q4 Form 20-F Financial Statement

#000121390024037934 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZCMD Zhongchao Inc Stock $zcmd

2023 Q4 Form 20-F Financial Statement

#000121390024037934 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZCMD
Zhongchao Inc Stock $zcmd